1-(3-Oxo-3,4-dihydroquinoxalin-2-yl)piperidine-4-carboxylic acid

Catalog No.: 
ACYLED585
CAS No.: 
1713461-83-6
Molecular Formula: 
C14H15N3O3
Molecular Weight: 
273.29
1-(3-Oxo-3,4-dihydroquinoxalin-2-yl)piperidine-4-carboxylic acid structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg97%$159.00InquiryInquiry
1g97%$508.00InquiryInquiry
5g97%$2515.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1-(3-Oxo-3,4-dihydroquinoxalin-2-yl)piperidine-4-carboxylic acid
IUPAC Name1-(3-oxo-3,4-dihydroquinoxalin-2-yl)piperidine-4-carboxylic acid
Molecular FormulaC14H15N3O3
Molecular Weight273.29
SMILESO=C(C1CCN(C2=NC3=C(C=CC=C3)NC2=O)CC1)O
InChI KeyAXFAIXNNRGAVSP-UHFFFAOYSA-N
Synonym1-(3-Oxo-3,4-dihydro-quinoxalin-2-yl)-piperidine-4-carboxylic acid;4-Piperidinecarboxylic acid, 1-(3,4-dihydro-3-oxo-2-quinoxalinyl)-
CAS No.1713461-83-6

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACYLED585 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACIWFN675 route compound structure diagram
    ACIWFN6755984-56-5In Stock
  2. Plus
  3. ACHVRZ804 route compound structure diagram
    ACHVRZ80435676-70-1In Stock
  4. Then
  5. ACYLED585 route product structure diagram
    ACYLED5851713461-83-6
Inquiry

2. ACYLED585 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACYLED585 route product structure diagram
    ACYLED5851713461-83-6
Inquiry

3. ACYLED585 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACYLED585 route product structure diagram
    ACYLED5851713461-83-6
Inquiry

Comments (0)